Calcii dobesilas monohydricus
This medicine should always be taken exactly as described in this package leaflet for the patient or as directed by a doctor or pharmacist.
The active substance of the medicine is calcium dobesilate monohydrate, which improves venous circulation and has a protective effect on blood vessels. It reduces the permeability of their walls and excessive blood and serum viscosity, preventing the formation of stasis and thrombosis in venous vessels.
Symptomatic treatment of chronic venous insufficiency of the lower limbs (pain and nocturnal cramps in the legs, feeling of heaviness in the legs, paresthesia, edema, skin changes due to blood stasis), varicose veins of the lower limbs.
Symptomatic treatment of hemorrhoids.
if the patient is allergic to calcium dobesilate monohydrate or any of the other ingredients of this medicine (listed in section 6).
Before starting treatment with Dobenox or Dobenox Forte, the patient should discuss it with their doctor or pharmacist.
The medicine should be used with caution if the patient has gastric or duodenal ulcer disease, or renal insufficiency.
The patient should stop taking the medicine immediately and contact their doctor if they experience symptoms such as fever, sore throat, difficulty swallowing, oral inflammation, nasal mucosa inflammation, genital or anal inflammation, as these may be symptoms of a serious disease - agranulocytosis.
1/4
The patient should inform their doctor or pharmacist about all medicines they are currently taking or have recently taken, as well as any medicines they plan to take.
The medicine should be taken after meals to avoid or minimize gastrointestinal side effects.
If the patient is pregnant or breastfeeding, or thinks they may be pregnant or plans to have a child, they should consult their doctor or pharmacist before taking this medicine.
The medicine is not recommended during the first trimester of pregnancy.
The medicine may be used during pregnancy only if, in the doctor's opinion, the benefit to the mother outweighs the potential risk to the fetus.
The medicine should not be used during breastfeeding.
The medicine does not affect the ability to drive or operate machines.
If the patient has previously been diagnosed with intolerance to some sugars, they should contact their doctor before taking the medicine.
1 tablet of Dobenox contains 25 mg of lactose.
1 tablet of Dobenox Forte contains 50 mg of lactose.
This medicine should always be taken exactly as described in this package leaflet for the patient or as directed by a doctor or pharmacist. If in doubt, the patient should consult their doctor or pharmacist.
The medicine is taken orally.
The medicine should be taken after meals.
Unless otherwise directed by a doctor, the usual dose for adults is 2 to 4 tablets per day (corresponding to a daily dose of 500 mg to 1000 mg of the active substance - calcium dobesilate monohydrate):
venous insufficiency - usually 2 tablets 1-2 times a day;
hemorrhoids - usually 2 tablets 1-2 times a day.
Unless otherwise directed by a doctor, the usual dose for adults is 1 to 2 tablets per day (corresponding to a daily dose of 500 mg to 1000 mg of the active substance - calcium dobesilate monohydrate):
venous insufficiency - usually 1 to 2 tablets per day;
hemorrhoids - usually 1 to 2 tablets per day.
In case of doubt, the patient should consult their doctor or pharmacist.
Treatment may last from several weeks to several months, depending on the indications.
There are no known symptoms of overdose.
In case of taking a higher dose of the medicine than recommended, the patient should immediately consult their doctor or pharmacist.
2/4
The patient should not take a double dose to make up for a missed dose.
In case of any further doubts about taking this medicine, the patient should consult their doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
The listed side effects usually disappear on their own after stopping treatment.
Uncommon side effects (occurring in 1 to 10 patients out of 10,000):
nausea, diarrhea,
skin reactions,
joint pain.
Rare side effects (occurring in less than 1 patient out of 10,000):
agranulocytosis - an acute condition that may manifest as high fever, infections in the mouth, sore throat, changes in the anus and genital area.
If the patient experiences any side effects, including any side effects not listed in this package leaflet, they should inform their doctor or pharmacist. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Aleje Jerozolimskie 181C, 02-222 Warsaw
tel.: 22 49 21 301, fax: 22 49 21 309
Website: https://smz.ezdrowie.gov.pl.
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help gather more information on the safety of the medicine.
Store in the original packaging, at a temperature below 25°C.
The medicine should be stored out of sight and reach of children.
Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the specified month.
Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
3/4
The active substance of the medicine is calcium dobesilate monohydrate.
1 tablet contains 250 mg or 500 mg of calcium dobesilate monohydrate.
The other ingredients (excipients) are: microcrystalline cellulose, potato starch, lactose monohydrate, talc, magnesium stearate, colloidal silica anhydrous, Opadry II 57U18539 White coating containing: hypromellose, polydextrose, titanium dioxide (E 171), talc, maltodextrin, medium-chain triglycerides.
Dobenox
Coated tablets - round, biconvex, white, with a uniform and smooth surface.
One package of Dobenox contains 30 coated tablets.
Dobenox Forte
Coated tablets - oval, biconvex, white, with a uniform and smooth surface.
One package of Dobenox Forte contains 30 or 60 coated tablets.
“PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNEJ HASCO-LEK” S.A.
51-131 Wrocław, ul. Żmigrodzka 242 E
Information about the medicine
tel. 22 742 00 22
e-mail: informacjaoleku@hasco-lek.pl
Date of Last Update of the Package Leaflet:03/2024
4/4
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.